UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
September 20, 2006
Date of Report (Date of Earliest Event Reported)
ALLERGAN, INC.
(Exact Name of Registrant as Specified in its Charter)
| |
|
|
|
|
Delaware
(State of Incorporation)
|
|
1-10269
(Commission File Number)
|
|
95-1622442
(IRS Employer
Identification Number) |
2525 Dupont Drive
Irvine, California 92612
(Address of Principal Executive Offices) (Zip Code)
(714) 246-4500
(Registrant’s Telephone Number, Including Area Code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 8.01. Other Events.
On September 20, 2006, Allergan, Inc. (“Allergan”) held a special meeting of stockholders. At the
special meeting and upon the recommendation of the Allergan board of directors, Allergan’s
stockholders approved an amendment to Allergan’s Restated Certificate of
Incorporation, as amended, to increase the total number of authorized shares of Allergan’s common
stock from 300,000,000 to 500,000,000. On September 20, 2006, Allergan filed a Certificate of
Amendment of Restated Certificate of Incorporation of Allergan, Inc. (the “Certificate of
Amendment”) with the Secretary of State of the State of Delaware, increasing the total number of
authorized shares of Allergan’s common stock from 300,000,000 to 500,000,000.
The foregoing description of the Certificate of Amendment is qualified in its entirety by the terms
of the Certificate of Amendment, which is filed as Exhibit 3.1 to and incorporated by reference in
this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
3.1 Certificate of Amendment of Restated Certificate of Incorporation of Allergan, Inc.